Cargando…
Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
Using a carcinogen-initiated rat model of mammary tumorigenesis, we tested the hypothesis that transforming growth factor (TGF)-βs are useful biomarkers of chemopreventive efficacy in the breast. The chemopreventive agents tested were tamoxifen and the retinoids 9-cis-retinoic acid (9cRA) and N-(4-h...
Autores principales: | Zujewski, JoAnne, Vaughn-Cooke, Anika, Flanders, Kathleen C, Eckhaus, Michael A, Lubet, Ronald A, Wakefield, Lalage M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13902/ https://www.ncbi.nlm.nih.gov/pubmed/11250748 |
Ejemplares similares
-
The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats
por: El Mesallamy, Hala O, et al.
Publicado: (2011) -
Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate
por: Xue, Chengsen, et al.
Publicado: (2014) -
Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model
por: Woditschka, Stephan, et al.
Publicado: (2008) -
Brightfield Proximity Ligation Assay Reveals Both Canonical and Mixed Transforming Growth Factor-β/Bone Morphogenetic Protein Smad Signaling Complexes in Tissue Sections
por: Flanders, Kathleen C., et al.
Publicado: (2014) -
Transforming growth factor-β and breast cancer: Lessons learned from genetically altered mouse models
por: Wakefield, Lalage M, et al.
Publicado: (2000)